Up 160% in a year, why this ASX 200 healthcare stock is surging again today

Pro Medicus Limited (ASX: PME) shares are having a good start to the session. In morning trade, the ASX 200 …

| More on:
Shot of a young scientist using a digital tablet while working in a lab.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Pro Medicus Limited (ASX: PME) shares are having a good start to the session.

In morning trade, the ASX 200 healthcare stock is up 3% to $261.50.

This builds on the 160% gain the health imaging technology company's shares had already recorded over the past 12 months.

Why is this ASX 200 healthcare stock surging?

Investors have been bidding the Pro Medicus share price higher today for a couple of reasons.

One reason is that Wall Street rallied higher overnight thanks to the release of favourable inflation data. This is giving the whole market a big boost this morning.

In addition, investors are responding positively to the release of an announcement from the ASX 200 healthcare stock today.

According to the release, the company has signed a $33 million, 9-year contract with the University of Kentucky (UK). It is the preeminent academic health system in the state of Kentucky.

The company notes that UK HealthCare is a comprehensive healthcare system that includes a network of hospitals, clinics, and specialised medical services. It is anchored by the UK Albert B. Chandler Hospital, which is a leading medical facility in the region, offering advanced treatment options and cutting-edge research.

It also highlights that the system includes the UK Good Samaritan Hospital, which provides a range of services including emergency care, surgery, and rehabilitation. Furthermore, it is affiliated with the University of Kentucky College of Medicine, ensuring a strong emphasis on education, research, and innovation.

What's the contract?

The release reveals that the contract is based on a transactional licensing model and will see the company's cloud-based Visage 7 Enterprise Imaging Platform, including Visage 7 Open Archive and Visage 7 Workflow modules, implemented throughout UK providing a unified diagnostic imaging platform.

Visage will complete the migration from UK's legacy PACS archive and vendor neutral archive to Visage 7 Open Archive. Visage 7 will also provide enterprise distribution of images integrated to UK's electronic health record (EHR).

Commenting on this latest contract win, the ASX 200 healthcare stock's CEO, Dr Sam Hupert, said:

University of Kentucky joins our growing list of academic clients. They also join a long list of Visage 7 clients to opt for a fully cloud-based solution, which, as a result of our CloudPACS strategy, is becoming the standard in the North American healthcare IT market.

Our pipeline remains strong and spans all market segments. As has been the case with many of our recent contracts, this deal is for our "full stack" comprising all three Visage products namely viewer, workflow and archive, a trend we see continuing.

Motley Fool contributor James Mickleboro has positions in Pro Medicus. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Person pretends to types on laptop drawn in sand.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a miserly session for investors today.

Read more »

Modern accountant woman in a light business suit in modern green office with documents and laptop.
Opinions

Too high? These 2 ASX shares might be due for a correction

These popular blue chips are looking dicey to me.

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Broker Notes

These ASX 200 shares could rise 20% to 35%

These shares are being tipped to deliver market-beating returns by analysts.

Read more »

Keyboard button with the word sell on it.
Broker Notes

8 ASX All Ords stocks downgraded to sell ratings

Find out which shares are out of favour with the experts.

Read more »

Woman smiling whilst shopping in a clothing store.
Dividend Investing

Why this quality ASX 300 dividend stock is tipped to surge 54%

A leading fund manager forecasts significant outperformance from this quality ASX 300 dividend stock.

Read more »

A group of businesspeople clapping.
Broker Notes

Bell Potter names more of the best ASX 200 stocks to buy in June

These stocks could be best buys this month according to the broker.

Read more »

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Share Market News

Why Clarity, Coronado Global, Iperionx, and Lynas shares are roaring higher today

These shares are having a strong session on Thursday. Why are investors buying them?

Read more »

A woman looks questioning as she puts a coin into a piggy bank.
Opinions

The ASX 200 is approaching its all-time high. Here's why I'm not buying shares

I'm not seeing what the broader market is.

Read more »